<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39348011</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>30</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1435-1250</ISSN><JournalIssue CitedMedium="Internet"><Volume>83</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Zeitschrift fur Rheumatologie</Title><ISOAbbreviation>Z Rheumatol</ISOAbbreviation></Journal><ArticleTitle>[Rheumatology in Germany in the SARS-CoV-2 pandemic].</ArticleTitle><Pagination><StartPage>517</StartPage><EndPage>519</EndPage><MedlinePgn>517-519</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00393-024-01573-0</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huppertz</LastName><ForeName>Hans-Iko</ForeName><Initials>HI</Initials><AffiliationInfo><Affiliation>, Schwachhauser Heerstr. 163a, 28211, Bremen, Deutschland. hihuppertz@hotmail.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Müller-Ladner</LastName><ForeName>Ulf</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Lehrstuhl für Innere Medizin, Schwerpunkt Rheumatologie, Abteilung für Rheumatologie und Klinische Immunologie, Kerckhoff-Klinik, Justus-Liebig-Universität Gießen, Campus Kerckhoff, Benekestr. 2, 61231, Bad Nauheim, Deutschland. rheumatologie@kerckhoff-klinik.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Specker</LastName><ForeName>Christof</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Klinik für Rheumatologie und Klinische Immunologie, Evangelisches Krankenhaus, Kliniken Essen-Mitte, Pattbergstr. 2, 45239, Essen, Deutschland. specker@hhu.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><VernacularTitle>Die deutsche Rheumatologie in der SARS-CoV-2-Pandemie.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Z Rheumatol</MedlineTA><NlmUniqueID>0414162</NlmUniqueID><ISSNLinking>0340-1855</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012219" MajorTopicYN="Y">Rheumatology</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012216" MajorTopicYN="Y">Rheumatic Diseases</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>12</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>11</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39348011</ArticleId><ArticleId IdType="doi">10.1007/s00393-024-01573-0</ArticleId><ArticleId IdType="pii">10.1007/s00393-024-01573-0</ArticleId></ArticleIdList><ReferenceList><Title>Literatur</Title><Reference><Citation>Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit, Robert Koch-Institut Beschreibung des bisherigen Ausbruchsgeschehens mit dem neuartigen Coronavirus SARS-CoV‑2 in Deutschland (Stand: 12. Februar 2020). Epid Bull 7:3–4. https://doi.org/10.25646/647</Citation></Reference><Reference><Citation>Ravens-Sieberer U et al (2021) Seelische Gesundheit und psychische Belastungen von Kindern und Jugendlichen in der ersten Welle der COVID-19-Pandemie – Ergebnisse der COPSY-Studie. Bundesgesundheitsbl 64:1512–1521. https://doi.org/10.1007/s00103-021-03291-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00103-021-03291-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Doenhardt M, Hufnagel M, Diffloth N et al (2024) Epidemiology of 7375 children and adolescents hospitalized with COVID-19 in Germany, reported via a prospective, nationwide surveillance study in 2020–2022. Sci Rep. https://doi.org/10.1038/s41598-023-49210-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-49210-1</ArticleId><ArticleId IdType="pubmed">38168119</ArticleId><ArticleId IdType="pmc">10762173</ArticleId></ArticleIdList></Reference><Reference><Citation>Horneff G et al (2004) The German etanercept registry for treatment of juvenile idiopathic arthritis. Ann Rheum Dis 63(12):1638–1644</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2003.014886</ArticleId><ArticleId IdType="pubmed">15115709</ArticleId><ArticleId IdType="pmc">1754849</ArticleId></ArticleIdList></Reference><Reference><Citation>Biontech Pfizer und BioNTech erhalten erste EU-Zulassung für einen COVID-19-Impfstoff. https://investors.biontech.de/de/node/9011/pdf . Zugegriffen: 21. Dez. 2020</Citation></Reference><Reference><Citation>Meyer-Bahlburg A (2024) SARS-CoV-2-Infektion und Autoimmunität. Z Rheumatol 83:34–40</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00393-023-01455-x</ArticleId><ArticleId IdType="pubmed">38108865</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>